Home
>
National Drug Code (NDC)
>
pravastatin sodium
pravastatin sodium - 65841-740-16 - (pravastatin sodium)
Drug Information of pravastatin sodium
| Product NDC: | 65841-740 |
| Proprietary Name: | pravastatin sodium |
| Non Proprietary Name: | pravastatin sodium |
| Active Ingredient(s): | 20 mg/1 & nbsp; pravastatin sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of pravastatin sodium
| Product NDC: | 65841-740 |
| Labeler Name: | Cadila Healthcare Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077751 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100330 |
Package Information of pravastatin sodium
| Package NDC: | 65841-740-16 |
| Package Description: | 90 TABLET in 1 BOTTLE (65841-740-16) |
NDC Information of pravastatin sodium
| NDC Code | 65841-740-16 |
| Proprietary Name | pravastatin sodium |
| Package Description | 90 TABLET in 1 BOTTLE (65841-740-16) |
| Product NDC | 65841-740 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pravastatin sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100330 |
| Marketing Category Name | ANDA |
| Labeler Name | Cadila Healthcare Limited |
| Substance Name | PRAVASTATIN SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
